Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1

The Raf family of protein kinases display differences in their abilities to promote the entry of quiescent NIH 3T3 cells into the S phase of the cell cycle. Although conditional activation of deltaA-Raf:ER promoted cell cycle progression, activation of deltaRaf-1:ER and deltaB-Raf:ER elicited a G1 arrest that was not overcome by exogenously added growth factors. Activation of all three deltaRaf:ER kinases led to elevated expression of cyclin D1 and cyclin E and reduced expression of p27Kip1. However, activation of deltaB-Raf:ER and deltaRaf-1:ER induced the expression of p21Cip1, whereas activation of deltaA-Raf:ER did not. A catalytically potentiated form of deltaA-Raf:ER, generated by point mutation, strongly induced p21Cip1 expression and elicited cell cycle arrest similarly to deltaB-Raf:ER and deltaRaf-1:ER. These data suggested that the strength and duration of signaling by Raf kinases might influence the biological outcome of activation of this pathway. By titration of deltaB-Raf:ER activity we demonstrated that low levels of Raf activity led to activation of cyclin D1-cdk4 and cyclin E-cdk2 complexes and to cell cycle progression whereas higher Raf activity elicited cell cycle arrest correlating with p21Cip1 induction and inhibition of cyclin-cdk activity. Using green fluorescent protein-tagged forms of deltaRaf-1:ER in primary mouse embryo fibroblasts (MEFs) we demonstrated that p21Cip1 was induced by Raf in a p53-independent manner, leading to cell cycle arrest. By contrast, activation of Raf in p21Cip1(-/-) MEFs led to a robust mitogenic response that was similar to that observed in response to platelet-derived growth factor. These data indicate that, depending on the level of kinase activity, Raf can elicit either cell cycle progression or cell cycle arrest in mouse fibroblasts. The ability of Raf to elicit cell cycle arrest is strongly associated with its ability to induce the expression of the cyclin-dependent kinase inhibitor p21Cip1 in a manner that bears analogy to alpha-factor arrest in Saccharomyces cerevisiae. These data are consistent with a role for Raf kinases in both proliferation and differentiation of mammalian cells.

[1]  N. Perrimon,et al.  Requirement of the Drosophila raf homologue for torso function , 1989, Nature.

[2]  J. Cleveland,et al.  Expression of raf family proto-oncogenes in normal mouse tissues. , 1990, Oncogene.

[3]  T. Hunter.  Cooperation between oncogenes , 1991, Cell.

[4]  E. Nishida,et al.  The MAP kinase cascade is essential for diverse signal transduction pathways. , 1993, Trends in biochemical sciences.

[5]  Richard Treisman,et al.  Transcriptional Regulation by Extracellular signals: Mechanisms and Specificity , 1995, Cell.

[6]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.

[7]  T. Hunter,et al.  Cyclins and cancer , 1991, Cell.

[8]  M. Wigler,et al.  Complex formation between RAS and RAF and other protein kinases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  E. Harlow,et al.  Identification of G1 kinase activity for cdk6, a novel cyclin D partner , 1994, Molecular and cellular biology.

[10]  P. Demoly,et al.  [Transgenic mice]. , 1992, Annales de dermatologie et de venereologie.

[11]  D. Morgan,et al.  Cell cycle control in normal and neoplastic cells. , 1992, Current opinion in genetics & development.

[12]  A. Lloyd,et al.  Cooperating oncogenes converge to regulate cyclin/cdk complexes. , 1997, Genes & development.

[13]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[14]  J. Cleveland,et al.  v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells. , 1994, Oncogene.

[15]  C. Marshall,et al.  Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein , 1997, Current Biology.

[16]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[17]  E. Hafen,et al.  Raf functions downstream of Rasl in the Sevenless signal transduction pathway , 1992, Nature.

[18]  K. Pumiglia,et al.  Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Y. Nishizuka,et al.  Proliferation of both somatic and germ cells is affected in the Drosophila mutants of raf proto‐oncogene. , 1988, The EMBO journal.

[20]  G. Hannon,et al.  Cloning and characterization of murine p16INK4a and p15INK4b genes. , 1995, Oncogene.

[21]  Stephen J. Elledge,et al.  Mice Lacking p21 CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control , 1995, Cell.

[22]  W. Kolch,et al.  Raf-1 protein kinase is required for growth of induced NIH/3T3 cells , 1991, Nature.

[23]  B. Woda,et al.  Detection of 5-bromo-2-deoxyuridine (BrdUrd) incorporation with monoclonal anti-BrdUrd antibody after deoxyribonuclease treatment. , 1993, Cytometry.

[24]  T. Haystead,et al.  Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. , 1992, Science.

[25]  Mark R. Smith,et al.  Requirement for c-ras proteins during viral oncogene transformation , 1986, Nature.

[26]  Anthony J. Muslin,et al.  Raf-1 kinase is essential for early Xenopus development and mediates the induction of mesoderm by FGF , 1993, Cell.

[27]  C. Albanese,et al.  Transforming p21ras Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions (*) , 1995, The Journal of Biological Chemistry.

[28]  N. Ahn,et al.  Transformation of mammalian cells by constitutively active MAP kinase kinase. , 1994, Science.

[29]  C. Pritchard,et al.  Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene , 1996, Current Biology.

[30]  N. Perrimon,et al.  There Must Be 50 Ways to Rule the Signal: The Case of the Drosophila EGF Receptor , 1997, Cell.

[31]  P. Warne,et al.  Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro , 1993, Nature.

[32]  Morrison Dk,et al.  The Raf-1 kinase as a transducer of mitogenic signals. , 1990 .

[33]  J. Bishop,et al.  Torso, a receptor tyrosine kinase required for embryonic pattern formation, shares substrates with the sevenless and EGF-R pathways in Drosophila. , 1993, Genes & development.

[34]  Richard Treisman,et al.  Functional analysis of a growth factor-responsive transcription factor complex , 1993, Cell.

[35]  M. Ewen,et al.  Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein , 1997, Nature.

[36]  R. Weinberg,et al.  The pathway to signal achievement , 1993, Nature.

[37]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[38]  T. Hunter.  Oncoprotein Networks , 1997, Cell.

[39]  C. Marshall,et al.  MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. , 1994, Current opinion in genetics & development.

[40]  M. Karin.  Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. , 1994, Current opinion in cell biology.

[41]  Paul W. Sternberg,et al.  C. elegans lin-45 raf gene participates in let-60 ras-stimulated vulval differentiation , 1993, Nature.

[42]  James M. Roberts,et al.  Inhibitors of mammalian G1 cyclin-dependent kinases. , 1995, Genes & development.

[43]  S. Fawell,et al.  Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. , 1993, Molecular endocrinology.

[44]  C. Guillouf,et al.  Induction of p21 (WAF-1/CIP1) during differentiation. , 1994, Oncogene.

[45]  P. Cohen,et al.  Activation of the MAP kinase pathway by the protein kinase raf , 1992, Cell.

[46]  C. Marshall,et al.  Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells , 1994, Cell.

[47]  J. L. Bos,et al.  ras oncogenes in human cancer: a review. , 1989, Cancer research.

[48]  A Sewing,et al.  High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[49]  W. Haser,et al.  Raf-1: A kinase currently without a cause but not lacking in effects , 1991, Cell.

[50]  I. Herskowitz.  MAP kinase pathways in yeast: For mating and more , 1995, Cell.

[51]  A. Deblasio,et al.  Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition , 1995, The Journal of cell biology.

[52]  R. Hipskind,et al.  v-raf confers CSF-1 independent growth to a macrophage cell line and leads to immediate early gene expression without MAP-kinase activation. , 1993, Oncogene.

[53]  James M. Roberts,et al.  Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein , 1996, The Journal of cell biology.

[54]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[55]  Rapp Ur.  Role of Raf-1 serine/threonine protein kinase in growth factor signal transduction. , 1991 .

[56]  E. Hafen,et al.  Genetics of signal transduction in invertebrates. , 1994, Current opinion in genetics & development.

[57]  D. Drucker,et al.  UVB radiation induces p21Cip1/WAF1 and mediates G1 and S phase checkpoints. , 1996, Oncogene.

[58]  R. Treisman,et al.  Regulation of transcription by MAP kinase cascades. , 1996, Current opinion in cell biology.

[59]  M. McMahon,et al.  Inhibition of platelet-derived growth factor- and epidermal growth factor-mediated mitogenesis and signaling in 3T3 cells expressing delta Raf-1:ER, an estradiol-regulated form of Raf-1 , 1994, Molecular and cellular biology.

[60]  Xin-Yuan Fu,et al.  Cell Growth Arrest and Induction of Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Mediated by STAT1 , 1996, Science.

[61]  J. Pouysségur,et al.  Cyclin D1 Expression Is Regulated Positively by the p42/p44MAPK and Negatively by the p38/HOGMAPK Pathway* , 1996, The Journal of Biological Chemistry.

[62]  M. J. Cormier,et al.  Primary structure of the Aequorea victoria green-fluorescent protein. , 1992, Gene.

[63]  G. Nolan,et al.  Production of high-titer helper-free retroviruses by transient transfection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Y. Wang,et al.  Regulation of the cell cycle machinery by oncogenic ras. , 1996, Oncogene.

[65]  S. Elledge,et al.  p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells , 1995, Science.

[66]  J. Abraham,et al.  Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. , 1995, Genes & development.

[67]  R. Palmiter,et al.  Oncogene-induced liver neoplasia in transgenic mice. , 1989, Oncogene.

[68]  C. Marshall,et al.  Ras recruits Raf‐1 to the plasma membrane for activation by tyrosine phosphorylation. , 1995, The EMBO journal.

[69]  Gustav Ammerer,et al.  FAR1 links the signal transduction pathway to the cell cycle machinery in yeast , 1993, Cell.

[70]  R. Treisman,et al.  The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain , 1993, Cell.

[71]  T. Roberts,et al.  The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells: a potential role for cellular raf kinases in neuronal growth factor signal transduction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[72]  U. Rapp.  Role of Raf-1 serine/threonine protein kinase in growth factor signal transduction. , 1991, Oncogene.

[73]  J. Bishop,et al.  Association of pRas and pRaf-1 in a complex correlates with activation of a signal transduction pathway , 1993, Current Biology.

[74]  M. McMahon,et al.  Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase , 1993, Molecular and cellular biology.

[75]  M. McMahon,et al.  Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1 , 1997, Oncogene.

[76]  F. Di Cunto,et al.  The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. , 1996, Genes & development.

[77]  P. Sternberg,et al.  Role of a raf proto-oncogene during Caenorhabditis elegans vulval development. , 1993, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[78]  V. Stanton,et al.  Definition of the human raf amino-terminal regulatory region by deletion mutagenesis , 1989, Molecular and cellular biology.

[79]  T. Curran,et al.  Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle , 1994, Molecular and cellular biology.

[80]  J. Downing,et al.  A point mutation at tyrosine-809 in the human colony-stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity, association with phosphatidylinositol 3-kinase, or induction of c-fos and junB genes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[81]  R. Mangues,et al.  Tumorigenesis and male sterility in transgenic mice expressing a MMTV/N-ras oncogene. , 1990, Oncogene.

[82]  I. Hariharan,et al.  A Cyclin-Dependent Kinase Inhibitor, Dacapo, Is Necessary for Timely Exit from the Cell Cycle during Drosophila Embryogenesis , 1996, Cell.

[83]  James M. Roberts,et al.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.

[84]  Robert A. Weinberg,et al.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes , 1983, Nature.

[85]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[86]  G. Evan,et al.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. , 1995, Nucleic acids research.

[87]  D. Morrison,et al.  The Raf-1 kinase as a transducer of mitogenic signals. , 1990, Cancer cells.

[88]  E. Krebs,et al.  Selective requirement for MAP kinase activation in thymocyte differentiation , 1995, Nature.

[89]  M. Noble,et al.  Ras‐mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. , 1988, The EMBO journal.

[90]  S. Elledge,et al.  Inhibition of cyclin-dependent kinases by p21. , 1995, Molecular biology of the cell.

[91]  Philip D. Jeffrey,et al.  Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex , 1996, Nature.

[92]  Kung,et al.  Induction of transformation and DNA synthesis after microinjection of raf proteins , 1990, Molecular and cellular biology.

[93]  A. Balmain,et al.  Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. , 1995, Cancer research.

[94]  James M. Roberts,et al.  A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 Kip1 -Deficient Mice , 1996, Cell.

[95]  A. Balmain,et al.  Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter , 1990, Cell.

[96]  L. Chin,et al.  Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.

[97]  D. Morrison,et al.  Biochemical analysis of torso and D-raf during Drosophila embryogenesis: implications for terminal signal transduction , 1993, Molecular and cellular biology.

[98]  E. Lees.  Cyclin dependent kinase regulation. , 1995, Current opinion in cell biology.

[99]  E. Hafen,et al.  Control of drosophila photoreceptor cell fates by phyllopod, a novel nuclear protein acting downstream of the raf kinase , 1995, Cell.

[100]  Yuh Nung Jan,et al.  Dacapo, a Cyclin-Dependent Kinase Inhibitor, Stops Cell Proliferation during Drosophila Development , 1996, Cell.

[101]  Charles J. Sherr,et al.  Mammalian G1 cyclins , 1993, Cell.

[102]  R. Palmiter,et al.  Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice , 1987, Cell.

[103]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[104]  R. Weinberg,et al.  Cellular oncogenes and multistep carcinogenesis. , 1983, Science.

[105]  C. Pritchard,et al.  Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells , 1995, Molecular and cellular biology.

[106]  X. F. Zhang,et al.  Raf meets Ras: completing the framework of a signal transduction pathway. , 1994, Trends in biochemical sciences.

[107]  Michael C. Ostrowski,et al.  Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1 , 1997, Molecular and cellular biology.

[108]  S Falkow,et al.  FACS-optimized mutants of the green fluorescent protein (GFP). , 1996, Gene.

[109]  Jonathan A. Cooper,et al.  Mammalian Ras interacts directly with the serine/threonine kinase raf , 1993, Cell.

[110]  T. Hunter,et al.  Dependence of Cyclin E-CDK2 Kinase Activity on Cell Anchorage , 1996, Science.